Press Releases
![](/media/z1lmbig5/press-releases-feature.jpg?width=1600&height=469&quality=70&meta=false&rnd=133326087643300000)
12 JULY 2020
Mallinckrodt and Terumo BCT Announce Positive Recommendations in Australia for Public Funding of UVADEX®(Methoxsalen) for ECP Administration with the THERAKOS® CELLEX® Photopheresis System for Treatment of Cutaneous T-Cell Lymphoma (CTCL) in Adults
31 AUGUST 2020
Mallinckrodt Announces 2020 Investigator Award to Further Advances in ECP Immunomodulation